Levels of high-sensitivity C-reactive protein in young and middle-aged working men
- Authors: Kirichenko A.A.1, Polyakova O.A.1, Dubovskaia I.N.2
-
Affiliations:
- Russian Medical Academy of Continuous Professional Education
- Diagnostic and Rehabilitation Center of Gazprom Transgaz Moscow
- Issue: Vol 23, No 1 (2021)
- Pages: 99-102
- Section: Articles
- URL: https://journals.rcsi.science/2075-1753/article/view/95461
- DOI: https://doi.org/10.26442/20751753.2021.1.200577
- ID: 95461
Cite item
Full Text
Abstract
Cardiovascular diseases remain the leading cause of death in the working age population. In recent decades, more and more attention has been attracted to a subacute chronic inflammatory process as the cause of the progression of atherosclerosis and the development of atherothrombosis. A high-sensitivity C-reactive protein (hs-CRP) is recognized as an independent marker of cardiovascular disease risk, comparable in value to cholesterol or blood pressure. Aim. Measurement of hs-CRP levels in the group of initially healthy young and middle-aged working men. Materials and methods. The study included 349 men aged 28 to 56 years, who undergo periodic medical examination at the Diagnostic and Rehabilitation Center of “Gazprom transgaz Moscow” OOO from November 2018 to February 2020.The examination was carried out according to an employee occupation by order of the Ministry of Health and Social Development of Russia No. 302n. dated 12.04.2011. Additionally, a blood test for hs-CRP was performed. Results. An increase in hs-CRP >2 mg/L was found in 26.7% of the men examined. In the majority of cases (89.2%), the increase in CRP ranged between 2 and 5 mg/L, in 7.5% of cases - between 5 and 10 mg/L, and only in 3,2% it exceeded 10 mg/L. All patients with elevated hs-CRP levels showed no signs of an acute inflammatory reaction. A direct correlation of hs-CRP levels with overweight and abdominal obesity, which increases with age, was revealed. In 151 men, hs-CRP levels were assessed in dynamics, of which baseline increase of >2 mg / l was noted in 28.5%, and after a year -in 23.2%. When assessing the absolute value of biomarker concentration, an increase in this indicator after a year was registered in 45.3% of men. Conclusion. The high incidence of increased baseline hs-CRP levels in the group of relatively healthy young and middle-aged working men, and the tendency for this indicator to increase after a year in 45.3% of men makes it appropriate to include routine measurement of the basal hs-CRP concentration in men over 40 years of age in screening programs and standards of medical examinations.
Full Text
##article.viewOnOriginalSite##About the authors
Andrey A. Kirichenko
Russian Medical Academy of Continuous Professional Education
Email: andreyapollonovich@yandex.ru
д-р мед. наук, проф. Moscow, Russia
Olga A. Polyakova
Russian Medical Academy of Continuous Professional Educationаспирант Moscow, Russia
Irina N. Dubovskaia
Diagnostic and Rehabilitation Center of Gazprom Transgaz Moscowзав. профпатологическим отд-нием, зав. поликлиническим отд-нием Moscow, Russia
References
- Catapano AL, Graham I, De Backer G, et al. 2016 ESC/EAS GUIDELINES FOR THE MANAGEMENT OF DYSLIPIDAEMIAS. Russian Journal of Cardiology 2017; 5: 7-77.
- Федеральная служба государственной статистики. Демографический ежегодник России -2019. Смертность. Режим доступа: https://gks.ru/bgd/regl/B19_16/Main.htm
- Глущенко В.А., Ирклиенко Е.К. Сердечно-сосудистая заболеваемость - одна из важнейших проблем здравоохранения. Медицина и организация здравоохранения. 2019; 1
- Mawhorter S, Lauer M. Is atherosclerosis an infectious disease? Clev Clinic J Med 2001; 68 (5): 449-58.
- Ridker PM, Hennekens CH, Buring JE, Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 2000; 342: 836-43.
- The Emerging Risk Factors Collaboration. C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis. Lancet 2010; 375: 132-40.
- Aday AW, Ridker PM. Targeting Residual Inflammatory Risk: A Shifting Paradigm for Atherosclerotic Disease. Front Cardiovasc Med 2019; 6: 16.
- Кардиоваскулярная профилактика 2017. Российские национальные рекомендации. Рос. кардиол. журн. 2018; 6: 7-122. doi: 10.15829/1560-4071-2018-6-7-122
- Магрук М.А., Мосикян А.А., Бабенко А.Ю. Биомаркеры, ассоциированные с атерогенезом: актуальный статус и перспективные направления. Рос. кардиол. журн. 2019; 24 (12): 148-52
- Погосова Н.В., Юферева Ю.М., Качанова Н.П., и др. Разработка алгоритма диагностики доклинического атеросклероза у пациентов из группы высокого риска развития сердечно-сосудистых заболеваний. Кардиология. 2020; 60 (2): 75-82. doi: 10.18087/cardio.2020.2.n964
- Arnett DK, Blumenthal RS, Albert MA, et al. 2019 ACC/AHA guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation 2019; 140: e596-e646.
- Российская ассоциация эндокринологов. Проект Клинических рекомендаций по ожирению 2019. Режим доступа: https://raeorg.ru/system/files/documents/pdf/kr_ozhirenie.pdf